Refer Me

Get ReferralsAI ApplyTailor ResumeFor YouPremium
Sign in
Fate Therapeutics

Fate Therapeutics

San Diego, California, United States

501-1000 Employees

Healthcare Tech

Senior Director, Supply Chain

San Diego, CA, US

Posted on Mar 13, 2026

Full TimeSeniorOn SiteTechnical Operations

Job Description

Fate Therapeutics is currently seeking a strategic and results-driven Senior Director, Supply Chain to lead end-to-end supply chain operations for our clinical programs. This role will oversee planning, procurement, warehousing and logistics, and global distribution, ensuring critical therapies reach patients on time. The successful candidate will drive cross-functional collaboration, process improvement, and data-driven solutions while leading a high-performing team. The ideal candidate has deep experience in GMP-regulated supply chains, a track record of strategic leadership, and a passion for optimizing operations in a fast-paced biotech environment. This is a full-time, exempt position located at our corporate headquarters in San Diego, California. 

About Fate Therapeutics

Fate Therapeutics (NASDAQ: FATE) is at the forefront of developing programmed cellular immunotherapies for cancer and immune disorders. The company's innovative approach harnesses the power of stem cells to create off-the-shelf, engineered cell therapies that have the potential to transform the treatment landscape. With a focus on precision medicine and cutting-edge research, Fate Therapeutics is revolutionizing the field of cellular immunotherapy.

Job overview

Employment type

Full Time

Experience level

Senior

Work type

On Site

Department

Technical Operations

Posted

on Mar 13, 2026

About

Job Link

jobs.lever.co

Financials

Type

public

Annual Revenue

--

Market Cap

$107.8M+

Subscribe to Refer Me premium to get referred to this role at Fate Therapeutics!

Your career is worth investing in.

Get unlimited referrals with Premium.

Upgrade to Premium

Refer Me logo

Refer Me

Referrals

Get Referred

Subscription

© 2026 Crucible Fund LLC. All rights reserved.